Population modeling to reduce bladder cancer burden
Official title: Population modeling for bladder cancer prevention and control
Funded at Brown University · NIH-11495895 · Data updated 2026-11-12
Aimed at predicting and guiding effective, population-based ways to prevent and control bladder cancer.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | September 18, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $1,231,387 |
| NIH project number | 1U01CA319218-01 |
| Project ID | NIH-11495895 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to a single patient group; findings will inform prevention and management for adults at risk or living with bladder cancer.
✕Less likely to help
Early-stage findings may not translate immediately into individual patient care.
What this research studies
This project uses population modeling to understand how prevention, screening, and treatments could reduce bladder cancer cases and deaths. It builds on recent biomarker and treatment advances to forecast impact at the population level and to optimize resource use. The work will inform decisions about policies, screening strategies, and treatment pathways that affect people at risk or living with bladder cancer. The focus is on translating complex data into actionable insights that could help patients receive better care.
Why it matters
Potential benefit: If successful, it could lead to more effective prevention and treatment strategies that reduce bladder cancer cases and improve patient outcomes.
How similar studies have gone: Previous population modeling efforts have shown potential to influence cancer prevention and care decisions, but disease-specific models for bladder cancer are evolving.
Where this research is happening
-
Brown University
Providence, United States Active
Researchers
- Principal investigator: Trikalinos, Thomas — Brown University
- Study coordinator: Trikalinos, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Blocking a new immune checkpoint in bladder cancer
Researchers are trying medicines that block a newly found immune pathway to help people with bladder cancer, especially those whose tumors do not respond to current immunotherapy.
-
Nrf2 in T cells and how it could boost immune power against bladder cancer
A small grant will explore how a T-cell protein called Nrf2 affects muscle-invasive bladder cancer and whether targeting it could help patients respond better to immune therapies.
-
Understanding why bladder cancer spreads and resists treatment
This grant studies how advanced bladder cancer changes and spreads across the body, aiming to uncover why it’s hard to treat.
-
Molecular clues to bladder cancer cell changes and therapy response
This NIH grant looks at how bladder cancer cells change their identity and how that affects response to treatment, with a focus on aggressive neuroendocrine variants.
-
Repurposing spironolactone to treat bladder cancer inside the bladder
Aims to repurpose spironolactone as an intravesical treatment for non-muscle invasive bladder cancer to help prevent recurrence and progression.
-
Racial and social factors linked to bladder cancer outcomes
This grant builds a partnership between Baylor College of Medicine and Texas Southern University to understand how people’s social and living conditions affect bladder cancer outcomes and treatment results.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.